Cellectis SA operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellectis SA with three other
companies in this sector in France:
Innate Pharma S.A.
sales of 56.16 million Euro [US$60.32 million]
(11.20 million Euro [US$12.03 million]
(22.49 million Euro [US$24.15 million]
Cellectis SA reported sales of 51.01 million Euro (US$54.79 million)
December of 2016.
decrease of 9.5%
versus 2015, when the company's sales were 56.39 million Euro.